Immune Thrombocytopenia Pipeline Immune Thrombocytopenia (ITP) is a chronic autoimmune disorder characterized by immune-mediated platelet destruction and impaired production, leading to increased bleeding risk and reduced quality of life. While corticosteroids, IVIG, and thrombopoietin receptor agonists (TPO-RAs) remain foundational treatments, … Continue reading →

IgG4-Related Disease Pipeline Insight IgG4-Related Disease (IgG4-RD) is a chronic immune-mediated condition affecting multiple organs and marked by elevated IgG4 levels, fibrosis, and inflammation. If untreated, it can lead to organ damage. Current therapies rely on corticosteroids and immunosuppressants, but … Continue reading →

Hypoparathyroidism Pipeline Hypoparathyroidism is a rare endocrine disorder caused by insufficient or absent secretion of parathyroid hormone, leading to hypocalcemia, hyperphosphatemia, and a range of neuromuscular and renal complications. Conventional treatment with calcium and active vitamin D supplements does not … Continue reading →

Hypereosinophilic Syndrome Pipeline Hypereosinophilic Syndrome (HES) is a rare group of disorders characterized by persistently elevated eosinophil levels, often leading to end-organ damage affecting the heart, lungs, skin, and nervous system. While corticosteroids remain the mainstay of treatment, their long-term … Continue reading →